Evidence map›Paper›PMID 28411158›Full record

ArticleNeuroscience2017

Intrinsic membrane properties and cholinergic modulation of mouse basal forebrain glutamatergic neurons in vitro.

Chun Yang, James T McKenna, Ritchie E Brown

Abstract read
In one paragraph

Article in Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Changes of membrane properties and synaptic stability of rat retinal ganglion cells during postnatal development].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  5. Article
  6. Basal forebrain contributes to default mode network regulation.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Chun YangVA Boston Healthcare System and Harvard Medical School, Department of Psychiatry, 1400 VFW Parkway, West Roxbury, MA 02132, USA. Electronic address: Chun_Yang@hms.harvard.edu.
James T McKennaVA Boston Healthcare System and Harvard Medical School, Department of Psychiatry, 1400 VFW Parkway, West Roxbury, MA 02132, USA. Electronic address: James_McKenna@hms.harvard.edu.
Ritchie E BrownVA Boston Healthcare System and Harvard Medical School, Department of Psychiatry, 1400 VFW Parkway, West Roxbury, MA 02132, USA; VA Boston Healthcare System and Harvard Medical School, Department of Psychiatry, Research 116A, 940 Belmont Street, Brockton, MA 02301, USA. Electronic address: Ritchie_Brown@hms.harvard.edu.
VA Boston Healthcare System · USHarvard University · US

Funding

Wakefulness and Forebrain Activation by Orexin NeuronsP01HL095491 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ARRIGONI, ELDA · 2010 to 2019
$25.1M
THE SYNAPTIC BASIS OF SLEEP CYCLE CONTROLR01MH039683 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BROWN, RITCHIE EDWARD · 1985 to 2017
$3.8M
vGLUT2-Tomato mice: a novel tool to study Basal Forebrain Glutamate NeuronsR21NS093000 · NINDS · HARVARD MEDICAL SCHOOL · PI BROWN, RITCHIE EDWARD · 2015 to 2016
$354k
Basal forebrain purinergic P2 receptor mechanisms of sleep-wake regulationR03MH107650 · NIMH · HARVARD MEDICAL SCHOOL · PI YANG, CHUN · 2016 to 2017
$129k
Sleep Spindles: Role of Thalamic Reticular Nucleus and Parvalbumin GABA NeuronsI01BX001356 · VA · VA BOSTON HEALTH CARE SYSTEM · PI BROWN, RITCHIE EDWARD · 2012 to 2020
–
Purinergic Mechanisms in Homeostatic Sleep ControlI01BX001404 · VA · VA BOSTON HEALTH CARE SYSTEM · PI BASHEER, RADHIKA · 2012 to 2021
–
BLRD VA I01 BX001356BLRD VA I01 BX001404NHLBI NIH HHS P01 HL095491NIMH NIH HHS R01 MH039683NIMH NIH HHS R03 MH107650NINDS NIH HHS R21 NS093000
6 · The paper itself

Abstract

The basal forebrain (BF) controls sleep-wake cycles, attention and reward processing. Compared to cholinergic and GABAergic neurons, BF glutamatergic neurons are less well understood, due to difficulties in identification. Here, we use vesicular glutamate transporter 2 (vGluT2)-tdTomato mice, expressing a red fluorescent protein (tdTomato) in the major group of BF glutamatergic neurons (vGluT2+) to characterize their intrinsic electrical properties and cholinergic modulation. Whole-cell, patch-clamp recordings were made from vGluT2+ neurons in coronal BF slices. Most BF vGluT2+ neurons were small/medium sized (<20µm), exhibited moderately sized H-currents and had a maximal firing frequency of ∼50Hz. However, vGluT2+ neurons in dorsal BF (ventral pallidum) had larger H-currents and a higher maximal firing rate (83Hz). A subset of BF vGluT2+ neurons exhibited burst/cluster firing. Most vGluT2+ neurons had low-threshold calcium spikes/currents. vGluT2+ neurons located in ventromedial regions of BF (in or adjacent to the horizontal limb of the diagonal band) were strongly hyperpolarized by the cholinergic agonist, carbachol, a finding apparently in conflict with their increased discharge during wakefulness/REM sleep and hypothesized role in wake-promotion. In contrast, most vGluT2+ neurons located in lateral BF (magnocellular preoptic area) or dorsal BF did not respond to carbachol. Our results suggest that BF glutamatergic neurons are heterogeneous and have morphological, electrical and pharmacological properties which distinguish them from BF cholinergic and GABAergic neurons. A subset of vGluT2+ neurons, possibly those neurons which project to reward-related areas such as the habenula, are hyperpolarized by cholinergic inputs, which may cause phasic inhibition during reward-related events.

Indexed as

Action PotentialsAnimalsAnimals, Genetically ModifiedAnimals, NewbornBasal ForebrainBenzamidesCalcium Channel BlockersCarbacholCholinergic AgentsElectric StimulationGlutamatesLuminescent ProteinsLysineMiceNeuronsPatch-Clamp Techniques3,5-dichloro-N-(1-(2,2-dimethyltetrahydropyran-4-ylmethyl)-4-fluoropiperidin-4-ylmethyl)benzamideBenzamidesbiocytinCalcium Channel BlockersCarbacholCholinergic AgentsGlutamatesICI D2788Luminescent ProteinsLysinePiperidinesPyrimidinesRed Fluorescent ProteinSodium Channel BlockersTetrodotoxinVesicular Glutamate Transport Protein 2Alzheimer’s diseasecortical activationpatch-clampsleepvesicular glutamate transporterwhole-cell

Identifiers

PMID28411158
PMCPMC5505269
OpenAlexW2605661471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.